Tumor hypoxia
From Wikidoc - Reading time: 2 min
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
|
WikiDoc Resources for Tumor hypoxia |
|
Articles |
|---|
|
Most recent articles on Tumor hypoxia Most cited articles on Tumor hypoxia |
|
Media |
|
Powerpoint slides on Tumor hypoxia |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Tumor hypoxia at Clinical Trials.gov Trial results on Tumor hypoxia Clinical Trials on Tumor hypoxia at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Tumor hypoxia NICE Guidance on Tumor hypoxia
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Tumor hypoxia Discussion groups on Tumor hypoxia Patient Handouts on Tumor hypoxia Directions to Hospitals Treating Tumor hypoxia Risk calculators and risk factors for Tumor hypoxia
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Tumor hypoxia |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
[edit | edit source]Tumor hypoxia is the situation where tumor cells have been deprived of oxygen. Hypoxic tumor cells usually resist to radiotherapy and chemotherapy [1] as they can be made more susceptible to treatment by increasing the amount of oxygen in them, but bioreductive prodrugs play a significant part in dealing with this kind of cells: they can kill the oxygen-deficient tumor cells selectively as hypoxic cytotoxins. Study of tumors in such conditions was pioneered by Dr L. H. Gray.
It can also be a result of the high degree of cell proliferation undergone in tumor tissue, causing a higher cell density, and thus taxing the local oxygen supply.
See also
[edit | edit source]References
[edit | edit source]- ↑ W. A. Denny, Prodrug strategies in cancer therapy, Eur. J. Med. Chem., 2001, 36, 577–595
EncycloReader
is supported by the 
KSF